[Editorial] Alzheimer's disease: evolution of research diagnostic criteria

The diagnosis of Alzheimer's disease in research settings has evolved rapidly over the past decade, with both the International Working Group (IWG) and the US National Institute on Aging and Alzheimer's Association (NIA-AA) contributing to endeavours to integrate biomarkers into research diagnostic criteria. These efforts have been important to distinguish the range of disease stages, from asymptomatic to severe dementia. The NIA-AA work group is now proposing a draft research framework that builds upon the 2011 NIA-AA and 2014 IWG criteria to include biomarkers more comprehensively than previously.
Source: Lancet Neurology - Category: Neurology Authors: Tags: Editorial Source Type: research